P2.04-69 Impact of Antibiotic Usage on Survival During Checkpoint Inhibitor Treatment of Non-Small Cell Lung Cancer (NSCLC)

Autor:	D. Wang, Gaurav Marwaha, Jeffrey A. Borgia, C. Hogue, Mary J. Fidler, P. Barry, Marta Batus, P. Bonomi, T. Kuzel
Rok vydání:	2019
Předmět:	Pulmonary and Respiratory Medicine Oncology business.industry medicine.drug_class Immune checkpoint inhibitors Antibiotics Cancer research Medicine non-small cell lung cancer (NSCLC) business medicine.disease
Zdroj:	Journal of Thoracic Oncology. 14:S735
ISSN:	1556-0864
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::283c5038198197155700336715474493 https://doi.org/10.1016/j.jtho.2019.08.1574 Zobrazit plný text záznamu